摘要
随着泌尿系肿瘤的发病率不断增高,肿瘤的高凝状态也越来越明显,高凝和纤溶亢进的风险也越来越高,常是早期的临床表现之一。随着肿瘤的进展,血栓风险增加,对患者的预后产生影响,因此,明确凝血功能的变化对抗凝或止血药物的使用至关重要,同时凝血功能等变化对评估患者预后也具有一定价值。
With the increasing incidence of urologic tumors, the hypercoagulable state of tumors is becoming more pronounced, and the risk of hypercoagulation and hyperfibrinolysis, often one of the early clinical manifestations, is increasing. As the tumor progresses, the risk of thrombosis increases, which has an impact on the patient’s prognosis. Therefore, it is crucial to clarify the changes in co-agulation function for the use of anticoagulant or hemostatic drugs, and also changes in coagulation function and other changes are of value in evaluating the patient’s prognosis.
出处
《临床医学进展》
2023年第10期16406-16411,共6页
Advances in Clinical Medicine
